Cargando…

Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients

BACKGROUND: Although gastrointestinal endoscopy with sedation is increasingly performed in elderly patients, data on combined sedation with midazolam/propofol are very limited for this age group. METHODS: We retrospectively analyzed 454 endoscopic procedures in 347 hospitalized patients ≥ 70 years w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerker, Astrid, Hardt, Christian, Schlief, Hans-Eugen, Dumoulin, Franz Ludwig
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823646/
https://www.ncbi.nlm.nih.gov/pubmed/20105314
http://dx.doi.org/10.1186/1471-230X-10-11
Descripción
Sumario:BACKGROUND: Although gastrointestinal endoscopy with sedation is increasingly performed in elderly patients, data on combined sedation with midazolam/propofol are very limited for this age group. METHODS: We retrospectively analyzed 454 endoscopic procedures in 347 hospitalized patients ≥ 70 years who had received combined sedation with midazolam/propofol. 513 endoscopic procedures in 397 hospitalized patients < 70 years during the observation period served as controls. Characteristics of endoscopic procedures, co-morbidity, complications and mortality were compared. RESULTS: Elderly patients had a higher level of co-morbidity and needed lower mean propofol doses for sedation. We observed no major complication and no difference in the number of minor complications. The procedure-associated mortality was 0%; the 28-day mortality was significantly higher in the elderly (2.9% vs. 1.0%). CONCLUSIONS: In this study on elderly patients with high level co-morbidity, a favourable safety profile was observed for a combined sedation with midazolam/propofol with a higher sensitivity to propofol in the elderly.